Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A pathway towards cures for Parkinson’s and cancer

06.11.2002


Researchers studying the Hedgehog signaling pathway have identified small molecules that could form the foundations of exciting new treatments for Parkinson’s disease and certain cancers.



New research published in Journal of Biology - the open access journal for exceptional research - has identified small molecules that are able to stimulate or block the Hedgehog signalling pathway, which is essential to the development, maintenance and repair of cells in the human body. The potential of these molecules to be used as drugs to treat both degenerative diseases and cancer is exciting as their small size may allow these molecules to enter all parts of the body and cross the blood brain barrier, eliminating the need for injections of therapeutics directly into the target site.

The Hedgehog signaling pathway is crucial to the development of healthy animals as well as the maintenance and repair of adult cells. Hedgehog genes were first identified in the fruitfly, and were so called because fly embryos with a defect in this gene were covered in bristles. The central role of the Hedgehog signalling pathway in the regulation of the growth and division of specific types of cells makes it of great interest to researchers investigating diseases like Parkinson’s that are characterised by a lack of particular cells as the central nervous system degenerates. Finding drugs that can stimulate the Hedgehog signaling pathway and lead to the production of new cells could potentially cure this disease. It is also hoped that by developing drugs that block the Hedgehog signalling pathway researchers will be able to induce the regression of tumours in patients with certain cancers that depend on this pathway (specifically, basal cell carcinoma and medulloblastoma).


Recent research has shown the Hedgehog protein can itself reduce the behavioural impairments and neuronal loss that occur in animal models of the Parkinson’s disease suggesting that manipulating this pathway may well deliver new treatment. One major drawback of using the Hedgehog protein to manipulate the signaling pathway is that, because of it large size, it has to be administered by direct injection into the brain.

In the Journal of Biology article, a team of researchers led by Jeffrey A Porter of the biotechnology company, Curis Inc, of Cambridge Massachusetts, and including colleagues from Columbia University in New York, report their screen of around 140,000 synthetic molecules for the ability to stimulate or inhibit the Hedgehog signalling pathway. One of the molecules was studied further by creating around 300 chemical derivatives. Using this method the researchers were able to identify a range of active molecules that could have exciting therapeutic benefits.

Porter and colleagues then went on to characterise the small synthetic molecules to find out how they worked in living organisms, hopeful that this would give them further understanding of the Hedgehog signalling pathway. They found their small molecules were interacting with a poorly understood protein that is found on the surface of developing cells. This protein, called Smoothened, helps cells respond to the Hedgehog protein.

The interaction of the Smoothened protein with the synthetic small molecules suggests that the Hedgehog signalling pathway may involve similar small molecules to those synthesised in this study.

The authors conclude, "As a drug a Hedgehog agonist [one of the new molecules they have identified] would represent an attractive alternative to an expensive Hedgehog protein therapeutic."


###
This article will be published online and made available free of charge on Wednesday November 6, in line with the publisher’s policy of providing immediate open access to original research: http://jbiol.com/1/2/10

The second issue of Journal of Biology will also include minireview and research news articles that will also be made freely available from http://jbiol.com, and which will be added to the press site ahead of publication.

Journal of Biology (http://jbiol.com) is a new international journal, published by BioMed Central, which provides immediate open access to research articles of exceptional interest. It will only publish research articles of the highest standard, similar to those published by Nature, Science or Cell. While these journals restrict access to only those who pay for a subscription, all research articles published in Journal of Biology will be permanently available free of charge and without restrictions, ensuring the widest possible dissemination of the work.

Contact details:

Journal of Biology
Editor Dr Theodora Bloom
E-mail editorial@jbiol.com
Telephone 44-207-323-0323
Facsimile 44-207-631-9961

Author Dr Jeffery A Porter, Curis, Inc.,
E-mail: jporter@curis.com
Telephone 617-503-6568
Facsimile 617-503-6501


Journal of Biology
Editor in Chief: Martin Raff
Publisher: BioMed Central
Format: online and print

Gordon Fletcher | EurekAlert!
Further information:
http://jbiol.com
http://jbiol.com/press/

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Small Protein, Big Impact

In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.

Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...

Im Focus: K-State study reveals asymmetry in spin directions of galaxies

Research also suggests the early universe could have been spinning

An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...

Im Focus: New measurement exacerbates old problem

Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.

Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Why developing nerve cells can take a wrong turn

04.06.2020 | Life Sciences

The broken mirror: Can parity violation in molecules finally be measured?

04.06.2020 | Physics and Astronomy

Innocent and highly oxidizing

04.06.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>